CD14+/IL-1β+ cells were significantly increased as well in MILD and severe AD compared to MCI and HC (p <0.05)(Fig. 6a), whereas lack of proper reagents prevented IL18-expressing cells to be analyzed by FACS. The gene discussed is IL18; the disease is Alzheimer disease.